Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAN 2022 | Ongoing trials investigating psychedelic-assisted therapies

Tadeusz Hawrot • 26 Jun 2022
EAN 2022
General Headache

Tadeusz Hawrot, Psychedelic Access and Research European Alliance (PAREA), describes ongoing clinical trials and research assessing the efficacy and safety of psychedelic-assisted therapies for the treatment of mental, neurological, and substance use disorders. Promising results are coming from studies looking at traumatic brain injury, post-traumatic stress disorder, and cluster headache. This interview took place at the European Academy of Neurology (EAN) 2022 Congress in Vienna, Austria.

More from Tadeusz Hawrot

PAREA: psychedelic-assisted therapies in Europe
6:12
PAREA: psychedelic-assisted therapies in Europe
Tadeusz Hawrot • 26 Jun 2022
The promise of psychedelic-assisted therapies
5:10
The promise of psychedelic-assisted therapies
Tadeusz Hawrot • 26 Jun 2022
Making neurological disorders a major global health priority
4:23
Making neurological disorders a major global health priority
Tadeusz Hawrot • 26 Jun 2022

Related Videos

PACAP-38 is increased in the tear fluid of patients with migraine
1:50
PACAP-38 is increased in the tear fluid of patients with migraine
Marina Romozzi • 27 Jun 2026
TRIPLE study: triple combination therapy for chronic migraine
2:41
TRIPLE study: triple combination therapy for chronic migraine
Marina Romozzi • 27 Jun 2026
Combination therapy for migraine: anti-CGRP, anti-PACAP, and onabotulinumtoxinA
8:49
Combination therapy for migraine: anti-CGRP, anti-PACAP, and onabotulinumtoxinA
Richard Lipton • 1 Jul 2026
CONFIDENCE: real-world consistency of response to rimegepant for the acute treatment of migraine
5:05
CONFIDENCE: real-world consistency of response to rimegepant for the acute treatment of migraine
Richard Lipton • 1 Jul 2026

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJNeurology is intended for healthcare professionals